Clinical Improvement in Job Syndrome Following Administration of Co-trimoxazole, Omalizumab and Inhaled Tobramycin
Abstract
Share and Cite
Papaioannou, O.; Karampitsakos, T.; Katsaras, M.; Sampsonas, F.; Tzouvelekis, A. Clinical Improvement in Job Syndrome Following Administration of Co-trimoxazole, Omalizumab and Inhaled Tobramycin. Adv. Respir. Med. 2021, 89, 585-588. https://doi.org/10.5603/ARM.a2021.0079
Papaioannou O, Karampitsakos T, Katsaras M, Sampsonas F, Tzouvelekis A. Clinical Improvement in Job Syndrome Following Administration of Co-trimoxazole, Omalizumab and Inhaled Tobramycin. Advances in Respiratory Medicine. 2021; 89(6):585-588. https://doi.org/10.5603/ARM.a2021.0079
Chicago/Turabian StylePapaioannou, Ourania, Theodoros Karampitsakos, Matthaios Katsaras, Fotios Sampsonas, and Argyrios Tzouvelekis. 2021. "Clinical Improvement in Job Syndrome Following Administration of Co-trimoxazole, Omalizumab and Inhaled Tobramycin" Advances in Respiratory Medicine 89, no. 6: 585-588. https://doi.org/10.5603/ARM.a2021.0079